Share
Journal Information
Most often read
13900
Diagnosis and treatment of chronic lymphocytic leukemia: 2025 recommendations of the Brazilian Group of Chronic Lymphocytic Leukemia of the Brazilian Association of Hematology and Hemotherapy (ABHH)
Carlos Sérgio Chiattone, Fernanda de Morais Marques, Valeria Buccheri, Mihoko Yamamoto, Sergio Costa Fortier, Maura Rosane Valerio Ikoma-Colturato, Nelson Hamerschlak, Vera Lucia de Piratininga Figueiredo, ... Brazilian Group of Chronic Lymphocytic Leukemia
Hematol Transfus Cell Ther. 2025;47: 103822
13900
Full text access
8669
DEFICIÊNCIA DE G6PD ‒ MUITAS DÚVIDAS A ESCLARECER
CG Costa
Hematol Transfus Cell Ther. 2025;47 Supl 3: 105059
8669
Full text access
7250
Ponatinib in the treatment of patients with chronic myeloid leukemia and increased cardiovascular risk: A review of management strategies
Tomasz Sacha, Katarzyna Krawczyk
Hematol Transfus Cell Ther. 2025;47: 103675
7250
Full text access
6593
Blood storage effect of G6PD on RBC quality
Andrew Evans Cobbinah, Benedict Sackey, Mina Ofosu, Herbert Ekoe Dankluvi, Stephen Opoku, Ampa Davis Frank
Hematol Transfus Cell Ther. 2025;47: 103733
6593
Full text access
6548
Chronic lymphocytic leukemia diagnosis: how many more algorithms and scoring systems do we need?
Daniel Mazza Matos
Hematol Transfus Cell Ther. 2025;47: 103668
6548
Full text access
6267
An approach to autologous stem cell mobilization: trying to define good mobilizers
Sara Montolio Chiva, Paula Gomez Fernandez, Antonio Manuel Gutiérrez Garcia, Maria del Carmen Ballester Ruiz, Antonia Sampol Mayol, Albert Perez Montaña
Hematol Transfus Cell Ther. 2025;47: 103688
6267
Full text access
6107
When innovation meets patient blood management – a new way to see bleeding
Guilherme Rabello, Rosangela Monteiro, Bianca Meneghini, Fabio Biscegli Jatene
Hematol Transfus Cell Ther. 2025;47: 103691
6107
Full text access
6067
BICITOPENIA E COMPLICAÇÕES HEMORRÁGICAS EM LEUCEMIA MIELOIDE CRÔNICA (LMC) E TRAUMATISMO CRANIOENCEFÁLICO
RA Martini, RAT Takaes, JMTD Souza, CZP Ferreira, IDB Bini, MV Galvan, MBB Stricker, CAd Souza, ... MC Capelin
Hematol Transfus Cell Ther. 2025;47 Supl 3: 104404
6067
Full text access
5862
Optimization of hydroxyurea in sickle cell disease in Brazil
Clarisse Lobo, Ana Cristina Silva-Pinto, Rodolfo Delfini Cançado
Hematol Transfus Cell Ther. 2025;47: 103826
5862
Full text access
5398
HEMOCROMATOSE HEREDITÁRIA: DIAGNÓSTICO E MANEJO
GPN Goequing, LF Alves, VS Baltieri, TMN Caldas, GLdS Cordeiro, LLdR Matos, VTdR MATOS, TG Salgado, ... LKAd Rocha
Hematol Transfus Cell Ther. 2025;47 Supl 3: 104078
5398
Full text access
5196
From the mechanism of action to clinical management: A review of cardiovascular toxicity in adult treated with CAR-T therapy
Frank Nunes, Breno Moreno de Gusmão, Franciely Bueno Wiginesk, Euler Manenti, Juliana Soares, Mizianne Garcia Freitas, Juliane Dantas Seabra-Garcez, Alexandre Manoel Varela, ... Ariane Vieira Scarlatelli Macedo
Hematol Transfus Cell Ther. 2025;47: 103693
5196
Full text access
4981
ECTASIA VASCULAR DO ANTRO GÁSTRICO (GAVE) EM ADOLESCENTE: DESAFIO DIAGNÓSTICO E IMPORTÂNCIA DA TERAPIA TRANSFUSIONAL NO SUPORTE AO TRATAMENTO ENDOSCÓPICO
EFG dos Santos, PMN Teixeira, ECRG Batalini, JC Gazola
Hematol Transfus Cell Ther. 2025;47 Supl 3: 106005
4981
Full text access
4702
Is galactomannan a useful tool for triage and diagnosis of oral invasive aspergillosis?
Maria Júlia Pagliarone, Lara Maria Alencar Ramos Innocentini, Fernanda Bortolotto, Vanessa Tonetto Marques Galves, Hilton Marcos Alves Ricz, Tatiane Cristina Ferrari, Renato Luiz Guerino Cunha, Belinda Pinto Simões, Leandro Dorigan de Macedo
Hematol Transfus Cell Ther. 2025;47: 103687
4702
Full text access
4668
Validation of an automated quality control method to test sterility of two advanced therapy medicinal products: Mesenchymal stromal cells and their extracellular vesicles
Carolina Kymie Vasques Nonaka, Zaquer Suzana Munhoz Costa-Ferro, Ana Carolina Palmeira Arraes, Thamires Lopes Weber, Luciana Souza de Aragão França, Katia Nunes Silva, Bruno Solano de Freitas Souza
Hematol Transfus Cell Ther. 2025;47: 103727
4668
Full text access
4509
Overall survival in multiple myeloma in Brazil: A cohort of 16 years
Deborah Marta do Santos Oliveira, Isabela Cristina Menezes de Freitas, Wallace Mateus Prata, Isabella Zuppo Laper, Pâmela Santos Azevedo, Adriano de Paula Sabino, Marisa Yurico Itonaga, Carmino Antonio de Souza, ... Augusto Afonso Guerra Junior
Hematol Transfus Cell Ther. 2025;47: 103962
4509
Full text access
4505
Efficacy, safety and satisfaction of using emicizumab in hemophilia A patients without factor VIII inhibitors: A systematic review
Isabela de Oliveira Araujo, Lucas Fernandes Suassuna, Isabela Lima dos Santos, Daniela de Oliveira Werneck Rodrigues
Hematol Transfus Cell Ther. 2025;47: 103849
4505
Full text access
4404
Updating the Brazilian clinical practice guidelines for sickle cell disease: Recommendations and development process
Ludmila Peres Gargano, Mariana Millan Fachi, Layssa Andrade Oliveira, Clarisse Lobo, Katharina Nelly Tobos Melnikoff, Selma Soriano, Marta da Cunha Lobo Souto Maior, Meline Rossetto Kron-Rodrigues, ... Rosa Camila Lucchetta
Hematol Transfus Cell Ther. 2025;47: 103964
4404
Full text access
4248
Assessing the contribution of myelofibrosis to a leukoerythroblastic blood picture
Stephen E. Langabeer
Hematol Transfus Cell Ther. 2025;47: 103735
4248
Full text access
4208
Annualized bleeding rate in hemophilia A patients in Brazil: a systematic review
Alessandra NL Prezotti, Débora MC Rocha, Endi L. Galvão, Thaís Gimenez, Leo Sekine, Rodrigo A. Ribeiro, Elisa Sobreira
Hematol Transfus Cell Ther. 2025;47: 103736
4208
Full text access
Publish in
Hematology, Transfusion and Cell Therapy
